Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
2.735
-0.040 (-1.44%)
At close: Jul 10, 2026, 4:00 PM EDT
2.690
-0.045 (-1.65%)
After-hours: Jul 10, 2026, 6:16 PM EDT

Xenetic Biosciences Revenue

Xenetic Biosciences had revenue of $806.92K in the quarter ending March 31, 2026, with 36.01% growth. This brings the company's revenue in the last twelve months to $3.19M, up 23.52% year-over-year. In the year 2025, Xenetic Biosciences had annual revenue of $2.98M with 19.04% growth.

Revenue (ttm)
$3.19M
Revenue Growth
+23.52%
P/S Ratio
1.96
Revenue / Employee
$1,595,037
Employees
2
Market Cap
6.27M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.98M476.13K19.04%
Dec 31, 20242.50M-39.71K-1.56%
Dec 31, 20232.54M833.06K48.80%
Dec 31, 20221.71M546.24K47.06%
Dec 31, 20211.16M723.75K165.64%
Dec 31, 2020436.94K419.88K2,460.31%
Dec 31, 201917.07K--
Dec 31, 2018---
Dec 31, 20177.59M4.59M152.83%
Dec 31, 20163.00M--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 20131.00M706.40K240.60%
Dec 31, 2012293.60K--
Aug 31, 2012---